Total Payments
$2,775
2024 Payments
$935.69
Companies
23
Transactions
112
Medicare Patients
6,805
Medicare Billing
$977,830
Payment Breakdown by Category
Food & Beverage$2,517 (90.7%)
Education$257.34 (9.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,517 | 104 | 90.7% |
| Education | $257.34 | 8 | 9.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $390.95 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $360.87 | 18 | $0 (2024) |
| Amgen Inc. | $237.67 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $228.89 | 11 | $0 (2024) |
| Travere Therapeutics, Inc. | $189.60 | 8 | $0 (2024) |
| AKEBIA THERAPEUTICS INC | $172.51 | 3 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $157.65 | 8 | $0 (2024) |
| Vifor Pharma, Inc. | $152.71 | 7 | $0 (2024) |
| NxStage Medical, Inc. | $128.84 | 2 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $126.98 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $935.69 | 41 | AstraZeneca Pharmaceuticals LP ($202.96) |
| 2023 | $661.94 | 31 | Bayer Healthcare Pharmaceuticals Inc. ($129.06) |
| 2022 | $768.78 | 28 | Amgen Inc. ($161.79) |
| 2021 | $50.73 | 3 | AKEBIA THERAPEUTICS INC ($24.84) |
| 2019 | $201.78 | 5 | AKEBIA THERAPEUTICS INC ($147.67) |
| 2018 | $145.30 | 3 | NxStage Medical, Inc. ($128.84) |
| 2017 | $10.35 | 1 | Amgen Inc. ($10.35) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.80 | General |
| Category: Cardio-renal | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: NEPHROLOGY | ||||||
| 12/09/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Hyperkalemia | ||||||
| 11/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $24.40 | General |
| 11/05/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Cardio-renal | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Nephrology | ||||||
| 09/18/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: NEPHROLOGY | ||||||
| 09/16/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $27.93 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/14/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/06/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 09/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $32.79 | General |
| Category: DIABETES | ||||||
| 08/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $35.11 | General |
| 08/23/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $3.67 | General |
| 08/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: Cardio-renal | ||||||
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: NEPHROLOGY | ||||||
| 08/07/2024 | Vifor Pharma, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Hyperkalemia | ||||||
| 08/06/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $19.23 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,814 | 3,224 | $511,757 | $229,286 |
| 2022 | 22 | 1,836 | 3,337 | $511,083 | $227,133 |
| 2021 | 24 | 1,857 | 3,551 | $611,073 | $282,858 |
| 2020 | 19 | 1,298 | 2,734 | $575,331 | $238,554 |
Total Patients
6,805
Total Services
12,846
Medicare Billing
$977,830
Procedure Codes
86
All Medicare Procedures & Services
86 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 401 | 845 | $179,985 | $84,694 | 47.1% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 26 | 156 | $91,747 | $44,438 | 48.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 154 | 516 | $73,489 | $33,772 | 46.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 118 | 143 | $56,940 | $20,415 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 103 | 103 | $33,784 | $13,647 | 40.4% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 19 | 49 | $23,698 | $12,037 | 50.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 50 | 155 | $23,827 | $9,281 | 39.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 236 | 316 | $5,113 | $1,777 | 34.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 85 | 134 | $3,580 | $1,375 | 38.4% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 27 | 32 | $2,560 | $1,294 | 50.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 91 | 153 | $2,295 | $1,276 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 15 | 16 | $2,304 | $1,168 | 50.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 79 | 121 | $2,730 | $915.94 | 33.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 211 | 249 | $2,988 | $839.13 | 28.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 45 | 51 | $1,909 | $669.12 | 35.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 24 | 28 | $1,314 | $460.88 | 35.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 50 | 65 | $939.90 | $330.20 | 35.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 28 | 34 | $922.08 | $323.68 | 35.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 15 | 17 | $716.04 | $251.26 | 35.1% |
| 82746 | Folic acid level, serum | Office | 2023 | 12 | 14 | $575.12 | $201.74 | 35.1% |
| 84550 | Uric acid level, blood | Office | 2023 | 25 | 27 | $340.74 | $119.61 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 352 | 749 | $159,537 | $72,309 | 45.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 27 | 151 | $88,806 | $44,348 | 49.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 163 | 544 | $77,476 | $32,978 | 42.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 106 | 129 | $51,365 | $21,547 | 41.9% |
About Dr. Sergio Obligado, MD
Dr. Sergio Obligado, MD is a Nephrology healthcare provider based in Goshen, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104035237.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sergio Obligado, MD has received a total of $2,775 in payments from pharmaceutical and medical device companies, with $935.69 received in 2024. These payments were reported across 112 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($2,517).
As a Medicare-enrolled provider, Obligado has provided services to 6,805 Medicare beneficiaries, totaling 12,846 services with total Medicare billing of $977,830. Data is available for 4 years (2020–2023), covering 86 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Goshen, NY
- Active Since 05/22/2007
- Last Updated 09/27/2012
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1104035237
Products in Payments
- Kerendia (Drug) $390.95
- FARXIGA (Drug) $264.24
- JYNARQUE (Drug) $228.89
- LUPKYNIS (Drug) $157.65
- AURYXIA (Drug) $147.67
- Tavneos (Drug) $144.90
- Veltassa (Drug) $140.57
- System One (Device) $128.84
- ELIQUIS (Drug) $126.98
- TERLIVAZ (Drug) $112.38
- LOKELMA (Drug) $96.63
- JARDIANCE (Drug) $75.02
- TAVNEOS (Drug) $61.50
- BENLYSTA (Biological) $54.37
- Crysvita (Drug) $51.81
- IBSRELA (Drug) $47.41
- RAYALDEE (Drug) $44.10
- Auryxia (Drug) $41.30
- Parsabiv (Biological) $31.27
- TARPEYO (Drug) $29.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.